Harmony Biosciences Holdings (HRMY) Amortizatization of Intangibles (2019 - 2026)

Harmony Biosciences Holdings' (HRMY) quarterly Amortizatization of Intangibles came in at $220000.0 in Q1 2026, down 96.31% year-on-year from $6.0 million in Q1 2025, and down 21.71% quarter-over-quarter from $281000.0 in Q4 2025.

Harmony Biosciences Holdings (HRMY) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends

Harmony Biosciences Holdings has disclosed Amortizatization of Intangibles across 8 years of filings, most recently posting $220000.0 for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $220000.0, down 96.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.4 million (down 68.91% YoY), and the FY2025 annual result was $1.5 million, down 93.62% from the prior year.
  • Amortizatization of Intangibles came in at $220000.0 for Q1 2026 at Harmony Biosciences Holdings, down from $281000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $22.1 million in Q4 2024 to a low of -$15.2 million in Q4 2023.
  • The 5-year median for Amortizatization of Intangibles is $6.0 million (2022), against an average of $4.6 million.
  • Across the five-year window, Amortizatization of Intangibles jumped 1825.0% in 2022 and sank 354.47% in 2023, its largest moves.
  • Harmony Biosciences Holdings' Amortizatization of Intangibles stood at $6.0 million in 2022, then tumbled by 354.47% to -$15.2 million in 2023, then surged by 245.53% to $22.1 million in 2024, then sank by 98.73% to $281000.0 in 2025, then slipped by 21.71% to $220000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $220000.0 (Q1 2026), $281000.0 (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Harmony Biosciences Holdings 1.92 Bn 1.28 Bn 170.88 Mn 220,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 220,000.00
Mar 31, 2026 220,000.00
Dec 31, 2025 281,000.00
Dec 31, 2025 281,000.00
Sep 30, 2025 5.96 Mn
Sep 30, 2025 5.96 Mn
Jun 30, 2025 5.96 Mn
Jun 30, 2025 5.96 Mn
Mar 31, 2025 5.96 Mn
Mar 31, 2025 5.96 Mn
Dec 31, 2024 22.08 Mn
Dec 31, 2024 22.08 Mn
Sep 30, 2024 5.96 Mn
Sep 30, 2024 5.96 Mn
Jun 30, 2024 5.96 Mn
Jun 30, 2024 5.96 Mn
Mar 31, 2024 5.96 Mn
Mar 31, 2024 5.96 Mn
Dec 31, 2023 -15.17 Mn
Dec 31, 2023 -15.17 Mn